-Bloomberg Citing European Official
Baird Maintains Outperform on Equifax, Raises Price Target to $237
Baird analyst Jeffrey Meuler maintains Equifax (NYSE:EFX) with a Outperform and raises the price target from $223 to $237.
Related Posts
Bitcoin Remains Above $20,000 Level; Here Are The Top Crypto Movers For Friday
Bitcoin (CRYPTO: BTC), the world’s most-valued cryptocurrency, managed to remain above the $20,000 level this morning on Friday.
AstraZeneca Announced Datopotamab Deruxtecan Showed Encouraging and Durable Efficacy in Patients With Heavily Pretreated HR-positive, HER2-Low or Negative Metastatic Breast Cancer
First results for AstraZeneca and Daiichi Sankyo's TROP2-directed ADC in this setting reported from TROPION-PanTumor01 Phase I trial. Pivotal TROPION-Breast01 Phase III trial is ongoing, evaluating datopotamab deruxtecan in these patients in earlier lines of treatment.
ReWalk Robotics Q3 EPS $(0.09) Misses $(0.06) Estimate, Sales $886.00K Miss $1.80M Estimate
ReWalk Robotics (NASDAQ:RWLK) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.06) by 50 percent. This is a 50 percent decrease over losses of $(0.06) per share from the